Cancer52 launches Manifesto for rare and less common cancers
Cancer52 is pleased to launch ‘The Other Half. A manifesto to transform outcomes for people with rare and less common cancers’. The...
Cancer52 Annual Review for 2022-2023
Cancer52 is proud to share its Annual Review for the financial year 2022-2023. As ever it is a great opportunity to look back at what has...
Cancer52 releases an analysis on rare and less common cancer research spend
In 2022, Cancer52 and the National Cancer Research Institute (NCRI) joined forces to create a report titled: Research into rare and less...